Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
3 studies found for:    21991951 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Study of Teriflunomide in Reducing the Frequency of Relapses and Accumulation of Disability in Patients With Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Drug: Teriflunomide;   Drug: Placebo (for teriflunomide)
2 Enrolling by invitation Teriflunomide Observational Effectiveness Study
Condition: Relapsing Remitting Multiple Sclerosis
Intervention: Drug: Teriflunomide
3 Recruiting Teriflunomide's Therapeutic Mechanisms of Action in Patients With Relapsing Remitting Multiple Sclerosis.
Condition: RELAPSING REMITTING MULTIPLE SCLEROSIS
Intervention:

Study has passed its completion date and status has not been verified in more than two years.